Skip to main content
. 2014 May 14;5(17):7420–7430. doi: 10.18632/oncotarget.1973

Figure 4.

Figure 4

Kaplan-Meier survival curves comparing months of survival in gastric cancer patients are shown for (A) methylated CpG site count of PAX5 promoter, (B) methylated status of CpG -236, (C) methylated status of CpG -183, (D) methylated status of CpG -162, and (E) methylated status of CpG -152.